June 1, 2023 - Bayer
3/01/2023 – Covered Entity Letter
Can CE get 340B pricing if they share claims data?
No (data sharing is voluntary)
Are system owned contract pharmacies exempted from this policy?
No
Can CEs with no in-house pharmacy designate a contract pharmacy for 340B pricing access?
Yes (CEs with no in-house pharmacies can select one additional CP for Adempas. The non Adempas CP has to be within 40 miles of the CE. No mileage restriction for Adempas CP. CEs with in-house pharmacies are allowed to designate one CP for Adempas.
Drugs affected by this policy:
All products except Aliqopa, Jivi, Kerendia, Kogenate, Kovaltry, Kyleena, Lampit, Mirena, Skyla, Nubeqa, Xofigo
Policy applies to what entity types?
Policy applies to hospitals covered entities only. Federal grantees are exempted from this policy.